Effect of Z-360, a novel orally active CCK-2/gastrin receptor antagonist on tumor growth in human pancreatic adenocarcinoma cell lines in vivo and mode of action determinations in vitro.

Source:http://linkedlifedata.com/resource/pubmed/id/17901954

Download in:

View as

General Info

PMID
17901954